• Brazil

in page functions
  • Brazil flag

  • Contributions and pledges over time (US$ millions)

     

    Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
     

    Notes:
    Direct Contributions (including Matching Fund)
    Received contributions: non-US$ contributions for 2000-2018 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014, 2015, 2016, 2017 and 2018, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

    Future contributions: non-US$ Direct Contribution and Matching Fund pledges for years 2019 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 December 2018 or using the rates applicable to any hedge agreement in place.

    IFFIm contributions
    Received contributions: non-US$ contributions for 2000-2018 are expressed in US$ equivalents as confirmed by the IBRD (World Bank).

    Future contributions: non-US$ contributions for years 2019 and beyond are expressed in US$ equivalents as follows:

    • Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements.
    • Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 December 2018.
    • These contributions have not been reduced by a notional 3% provision to allow for any potential reduction arising from the High Level Financing Condition of the IFFIm Finance Framework Agreement.

     

  • Funding history

    Brazil has an increasing role as a political and economic actor in developed and developing countries, sustaining its long-standing commitment in ensuring access to medicines and vaccines at the domestic, regional and international level. The Ministry of Health strategy includes the promotion of Brazil’s science and technology complex, the country’s Brazilian presence in multilateral health forums and engagement in international health issues; regional health integration and international humanitarian health support. Brazil’s state-owned vaccine manufacturer Bio-Manguinhos is a supplier of yellow fever vaccine to Gavi.

    As part of its international engagement strategy to strengthen global immunization efforts, in 2006 Brazil pledged USD 20 million over 20 years to IFFIm. Legislative approval was granted by Congress on 31 May 2011 to allow Brazil to make contributions to Gavi, completing the first payment in November 2018.

    Contributions and pledges in total:

    • IFFIm: USD 20 million over 20 years.
close icon

modal window here